(0.08%) 5 521.50 points
(0.11%) 39 889 points
(0.20%) 19 791 points
(0.02%) $81.65
(0.43%) $2.82
(-0.30%) $2 337.30
(0.07%) $29.55
(0.23%) $1 004.10
(0.04%) $0.932
(0.04%) $10.54
(0.02%) $0.788
(-0.85%) $87.25
3.17% $ 0.0960
Live Chart Being Loaded With Signals
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 231 126 |
Średni wolumen | 132 918 |
Kapitalizacja rynkowa | 6.50M |
EPS | $-0.320 ( Q1 | 2023-05-18 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0980 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00400 (4.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-03 | Khanna Ashish | Buy | 375 000 | Stock Option (Right to Buy) |
2023-01-03 | Riedel Norbert G | Buy | 420 000 | Stock Option (Right to Buy) |
2023-01-03 | Kidd Andrew | Buy | 700 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 16 590 862 | Sell: 1 518 818 |
Wolumen Korelacja
Aptinyx Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aptinyx Inc Korelacja - Waluta/Towar
Aptinyx Inc Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2021 |
Przychody: | $1.00M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
Przychody: | $1.56M |
Zysk brutto: | $1 564.00 (0.10 %) |
EPS: | $-1.020 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aptinyx Inc
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej